| Literature DB >> 23840587 |
Paul Capewell1, Stephanie Monk, Alasdair Ivens, Paula Macgregor, Katelyn Fenn, Pegine Walrad, Frederic Bringaud, Terry K Smith, Keith R Matthews.
Abstract
The gene expression of Trypanosoma brucei has been examined extensively in the blood of mammalian hosts and in forms found in the midgut of its arthropod vector, the tsetse fly. However, trypanosomes also undergo development within the mammalian bloodstream as they progress from morphologically 'slender forms' to transmissible 'stumpy forms' through morphological intermediates. This transition is temporally progressive within the first wave of parasitaemia such that gene expression can be monitored in relatively pure slender and stumpy populations as well as during the progression between these extremes. The development also represents the progression of cells from translationally active forms adapted for proliferation in the host to translationally quiescent forms, adapted for transmission. We have used metabolic labelling to quantitate translational activity in slender forms, stumpy forms and in forms undergoing early differentiation to procyclic forms in vitro. Thereafter we have examined the cohort of total mRNAs that are enriched throughout development in the mammalian bloodstream (slender, intermediate and stumpy forms), irrespective of strain, revealing those that exhibit consistent developmental regulation rather than sample specific changes. Transcripts that cosediment with polysomes in stumpy forms and slender forms have also been enriched to identify transcripts that escape translational repression prior to transmission. Combined, the expression and polysomal association of transcripts as trypanosomes undergo development in the mammalian bloodstream have been defined, providing a resource for trypanosome researchers. This facilitates the identification of those that undergo developmental regulation in the bloodstream and therefore those likely to have a role in the survival and capacity for transmission of stumpy forms.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23840587 PMCID: PMC3694164 DOI: 10.1371/journal.pone.0067069
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Escape from translational repression during differentiation from bloodstream to procyclic forms.
A. Mean scintillation counts ± standard error of [35S]-methionine incorporation during 1 hour windows throughout the differentiation from stumpy forms to procyclic forms (n = 3). Samples were taken at various time-points, shown in hours (h), post-addition of cis-aconitate (6mM); 0 h represents stumpy form cells. Established procyclic form cells (427 449 strain; PCF) and slender bloodstream monomorphic cells (single marker strain; BSF) were also analysed for comparison. Shown on the right y-axis is the mean count as a percentage of the mean count for established procyclic form cells (100%), these values also being shown above each data point. The experiment was performed twice and the numbers in parentheses are those obtained from the second experiment. B. Visualization of protein synthesis throughout differentiation by [35S]-methionine labelling. 6mM cis-aconitate was added to stumpy form T. b. brucei AnTat1.1 cells; samples were then labelled with [35S]-methionine for one hour at the time indicated post-addition of cis-aconitate (hr). The 0 hr time-point represents stumpy form cells. Monomorphic slender bloodstream form (BSF) and established procyclic form (PCF) cultures were also analysed. Protein samples were separated by SDS-PAGE (10%) and stained with Coomassie (left hand panel) to show loading or assayed by fluorography (right hand panel) to detect [35S]-labelled proteins. The major labelled bands are tubulin and VSG (for Slender forms), which closely migrate. Stumpy forms show less obvious VSG since MSP-B and GPI-PLC activity during parasite isolation and pre-incubation before labelling resulted in a significant loss of cell-associated VSG.
Figure 2Comparison of the relative expression of genes in different strains of T. brucei at different life cycle stages.
Scatter plots of mRNA abundance are shown of Slender (Panel A), Intermediate (Panel B) and Stumpy forms (panel C) using material derived from T. brucei AnTat1.1 (x axis) and T. brucei EATRO (y axis) parasites.
Figure 3Validation of expression profiles detected by the transcriptome study.
A. Realtime qRT PCR data for the relative expression of five transcripts predicted to be enriched in stumpy forms. mRNAs from slender and stumpy forms were subject to real time qRT-PCR using a constitutive transcript, GPI8, as a normalisation control. Although the scale of relative expression in each case differed from the global transcriptome study the direction of change, and the enrichment of each transcript in stumpy forms, was consistent, with the exception of Tb927.8.6990. B. qRT PCR products of the test transcripts in panel A, validating differential expression. In each case GPI8, which does not show statistically significant variation between life cycle stages, provided the normalisation control [58].
Figure 4Expression profile of Tb927.7.3150.
A. Northern blot validation of the developmental expression of transcript Tb927.7.3150. RNA from monomorphic slender (M) and pleomorphic slender (Sl), intermediate (Int) and stumpy (St) forms of T. brucei AnTat 1.1 was hybridized with riboprobes specific for either Tb927.7.3150 (left hand panel) or a control transcript Tb09.211.3970. The expression of Tb927.7.3150 progressively increases from slender to intermediate, being highest in stumpy forms. B. Realtime qRTPCR of the relative expression of Tb927.7.3150 in slender and stumpy forms of T. brucei AnTat 1.1. Transcript Tb927.10.13860 (GPI8) provided the normalisation control.
Pathways whose components exhibit elevated, or decreased, expression in stumpy forms.
| Change | Process | Members | Number changed | % Changed |
|
| Respiratory chain | 80 | 71 | 89 |
|
| Mitochondrial carrier | 25 | 12 | 48 |
|
| TCA cycle | 16 | 10 | 62 |
|
| Sphingolipid Biosynthesis | 11 | 11 | 100 |
|
| Fatty Acid Biosynthesis | 13 | 8 | 62 |
|
| Glycolysis | 43 | 19 | 44 |
|
| Proline and Glutamine Metabolism | 8 | 3 | 38 |
Figure 5RNA interference against Tb927.7.3150 does not perturb differentiation in vivo.
A. Realtime qRT PCR analysis of the expression and RNAi mediated knockdown of Tb927.7.3150 mRNA in pleomorphic T. brucei AnTat1.1 90:13 cells. Samples were derived from rodent infections with RNAi being induced by doxycycline provided in the drinking water. RNAi induction generated depletion of the Tb927.7.3150 transcripts to levels below that detected in slender forms. B. Progression of the course of parasitaemia of Tb927.7.3150 RNAi lines induced (solid lines), or not (dashed lines), to deplete the target transcript. No difference in the progression of the parasitaemia was observed whether RNAi was induced or not. n = 3. C. Tb927.7.3150 parasites either induced (solid lines), or not (dashed lines), were harvested from rodent infections once predominantly stumpy in morphology (on day 7 post infection for both induced and uninduced samples). Their differentiation to procyclic forms was then monitored by the expression of EP procyclin. In both cases the expression of this differentiation marker was equivalent regardless of the knockdown of Tb927.7.3150 mRNA levels.
Figure 6Polysome profiles of slender and stumpy T. brucei AnTat1.1.
In each case the derived UV absorbance at 260nm was used to detect the polysomal fractions. Stumpy polysomal material was derived from a pool from 4 mouse infections, with RNA being isolated simultaneously and in parallel. Slender polysome material was isolated from six flasks of 50ml culture. RNA was prepared from fractions 10–13 and these were used to assay transcript levels via digital SAGE. RNA prepared from the polysome enriched fractions are shown to the right hand side in each case. These were pooled for Digital SAGE expression analysis.
Transcripts enriched ≥3× in polysomal material compared to total mRNA in stumpy forms.
| Gene ID | Stumpy Mean Expession | Stumpy Polysome Mean Expression | Log2 Fold Change | Product Description |
|
| 2.25 | 27.54 | 3.61 | acid phosphatase, putative |
|
| 2.25 | 22.21 | 3.30 | choline dehydrogenase, putative |
|
| 10.13 | 44.43 | 2.13 | G-actin binding protein, putative,CAP/Srv2p, putative |
|
| 14.63 | 58.64 | 2.00 | hypoxanthine-guanine phosphoribosyltransferase (HGPRT) |
|
| 637.01 | 2538.51 | 1.99 | hypothetical protein, conserved (pseudogene) |
|
| 33.76 | 123.50 | 1.87 | proteasome regulatory non-ATPase subunit 11,19S proteasome regulatory subunit, Metallo-peptidase, Clan MP, Family M67 (RPN11) |
|
| 52.90 | 184.81 | 1.80 | hypothetical protein, conserved |
|
| 76.53 | 266.56 | 1.80 | hypothetical protein, conserved |
|
| 262.23 | 900.07 | 1.78 | cyclophilin a,cyclophilin type peptidyl-prolyl cis-trans isomerase (CYPA) |
|
| 108.04 | 370.51 | 1.78 | hypothetical protein, conserved |
|
| 30.39 | 103.96 | 1.77 | HNRNPA (HNRNPA) |
|
| 1247.01 | 4248.03 | 1.77 | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative |
|
| 104.67 | 354.52 | 1.76 | hypothetical protein, conserved |
|
| 1188.49 | 3903.28 | 1.72 | hypothetical protein, conserved |
|
| 1556.52 | 5096.57 | 1.71 | heat shock protein DNAJ, putative |
|
| 276.86 | 878.75 | 1.67 | hypothetical protein, conserved |
|
| 477.20 | 1507.82 | 1.66 | hypothetical protein, conserved |
|
| 108.04 | 341.19 | 1.66 | cytochrome c oxidase assembly factor, putative,electron transport protein SCO1/2, putative |
|
| 175.57 | 550.88 | 1.65 | hypothetical protein, conserved |
|
| 140.68 | 439.82 | 1.64 | tryparedoxin |
|
| 3179.43 | 9918.59 | 1.64 | hypothetical protein, conserved |
|
| 2311.70 | 7205.04 | 1.64 | kinetoplastid membrane protein KMP-11 (KMP-11) |
|
| 522.21 | 1608.23 | 1.62 | hypothetical protein, conserved |
|
| 159.82 | 489.58 | 1.62 | hypothetical protein, conserved |
|
| 4025.78 | 12326.48 | 1.61 | 10 kDa heat shock protein, putative (HSP10) |
|
| 3018.49 | 9156.23 | 1.60 | hypothetical protein, conserved |
|
| 621.26 | 1882.78 | 1.60 | proteasome beta 5 subunit, putative,proteasome beta 5 subunit (PRCE) |
|
| 534.59 | 1608.23 | 1.59 | hypothetical protein, conserved |
|
| 3127.66 | 9387.25 | 1.59 | nucleoside diphosphate kinase (NDPK) |
Figure 7PAD2 is expressed predominantly only upon cold shock of stumpy forms.
Western blot for the expression of PAD 2 in stumpy forms freshly harvested from a rodent infection (ST) or incubated in HMI9 medium at either 20°C or 37°C. PAD2 expression is clear at 20°C but little is expressed at 37°C. This matches the analysis previously reported by Dean et al 2009 [10]. Analysis of the same samples using an antibody to trypanothione synthetase (TS) provided a loading control.
Figure 8Validation of the polysomal enrichment of test mRNAs predicted from Digital SAGE analysis to exhibit elevated abundance in stumpy polysomal fractions.
Total (T) and polysomal (P) mRNA mRNA derived from monomorphic slender and pleomorphic stumpy forms is shown, these being hybridized with riboprobes detecting Tb09.211.2300, or Tb927.8.5120. Both transcripts were confirmed as showing enrichment in stumpy form polysomal RNAs with respect to both stumpy total RNA and slender total and polysomal mRNA. Some smearing is evident in the polysomal material of slender and stumpy forms reflecting some non-specific cross reactivity with other transcripts; an absence of significant RNA degradation is evidenced by the integrity of rRNA bands on the ethidium bromide-stained formaldehyde gel. Realtime qRT PCR of two further transcripts provided confirmation of their respective enrichment in polysome-derived material.